Purpose: Retinopathy of prematurity (ROP) is the leading cause of preventable blindness in premature infants. Antivascular endothelial growth factor (anti-VEGF) therapy has been used increasingly in treatment as a pharmacological alternative to laser therapy. In this study. we evaluate the results of low-dose anti-VEGF treatments. https://threadheaders.shop/product-category/custom-hoodie/